RDY and COYA Related Headlines

Go Back

Aug 25, 2025 08:00AM Coya Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) Application for COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

RDY and COYA Related Press Releases

Go Back

Aug 25, 2025 08:00AM Coya Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) Application for COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

RDY and COYA Related SEC Filings

Go Back